Single port entry – Are there any advantages?




Minimal-invasive, single-port laparoscopic surgery is a recent innovation that may improve surgical outcomes. In this chapter, we review published research on single-port surgery in gynaecology, and the different surgical instruments available. Challenges, advantages, indications and potential future rules of this new approach are also discussed. Sixty-five studies were available for review: 17 case reports, 32 case studies, 13 retrospective comparative studies, and three randomised-controlled trials (RCTs). The recent availability of advanced instruments has made single-port surgery safer and more feasible for most benign gynaecologic surgeries. Single-port surgery has many potential benefits, but comparative trials have found no differences between single-port surgery and conventional laparoscopy in postoperative complications, postoperative pain, hospital stay, and cosmetic results. Single-port surgery seems to provide another option in the area of minimal invasive surgery, and further development of this technique, along with robotics and natural orifice transgastric endoscopic surgery, will improve dissemination of this approach.


Introduction


One of the more recent advances in the field of minimally invasive gynaecology is the increasing use of single-port surgery (SPS). Single-port access laparoscopy (SPAL) is an attractive surgical approach because of its potential benefits and advantages. Trans-umbilical endoscopy has no additional abdominal incisions and, therefore, abdominal wound infections and incisional hernias could potentially be avoided. This could translate into less pain and improved cosmesis. Single-port surgery has developed rapidly in the past 3–4 years as an alternative to scarless natural orifice transluminal endoscopic surgery, which still remains experimental.


A recent systematic review by Ahmed et al. identified 102 clinical studies on SPAL in general, urologic, and gynecologic surgery, most of them conducted within the last 5 years.


Gynaecological surgeons pioneered pelvic SPS, as thousands of tubal ligation were carried out using single-incision laparoscopes with an offset eyepiece. In the 1970s, several gynaecologists carried out laparoscopic tubal sterilisation through a single umbilical incision. More advanced laparoscopic procedures using single-port surgery were reported years later, with the first single-port laparoscopic hysterectomy reported Pelosi and Pelosi in 1991. Improvement in traditional laparoscopic techniques, and availability of more advanced instruments, has made single-incision laparoscopy more feasible and safer. In this chapter, we review the published literature on SPS gynaecology ( Table 1 ), and present the different surgical instruments available. We also discuss challenges, advantages, indications and potential future rules of this new approach.



Table 1

Single-port surgery procedures in gynaecology.






















































































































































































































































































































































































































































































































































































































Source, year Study type Surgery type Indication (benign or malign) Number of participants Mean operative time (minutes) Complications, including conversion to open procedure.
1 Lambaudie et al., 2012 CS Extra peritoneal aortic lymphadenectomy M 13 180 None.
2 Hoyer-Sorensen et al., 2012 RCT Adnexal surgery (SPL vs LPS) B e M 40 (20 v 20) 42 v 31 2 (2 wound infections) v 1 (urinary retention).
3 Fagotti et al., 2012 RC TLH (SPL vs R-LPS) M 150 (75 v 75) 122 v 175 5 (3 insertion additional port + 1 vaginal dehiscence + 1 wound infection) v 7 (2 conversion to mini-laparotomy access + 2 vaginal dehiscences + 1 intestinal volvulus + 1 suppurated lymphocyst + 1 late ureteral stenosis).
4 Fanfani et al., 2012 RC TLH (LPS vs M-LPS vs SPL) B e M 85 (30 v 25 v 30) 80 v 90 v 105 None v 2 (1 intraoperative haemorrhage + urinary infection) v 1 (intraoperative haemorrhage).
5 Li et al., 2012 RC TLH (SPL vs LPS) B 52 v 56 130 v 112 13 (1 wound infection + 12 fever) v 19 (5 wound infections + 14 fever).
6 Behnia-Willison et al., 2012 CS Endometriosis, OC adhesiolysis, TLH, PSP B 84/105 73 4 insertion of additional ports because of surgical difficulties, 1 intra-operative uterine perforation, 6 wound infections, 1 vault haematoma.
7 Song et al., 2012 CS Adnexal surgery B 115 83 1 (laparotomic conversion).
8 Kim et al., 2012 RC Adnexal surgery (SPL vs LPS) B 188 (94 v 94) 78 v 69 6 insertion of additional ports v none.
9 Lin et al., 2012 CR Intraperitoneal chemotherapy port placement 1 NA None.
10 Wang et al., 2012 RC TLH (SPL vs LPS) B 56 (28 v 28) 93 v 79 5 (1 bladder lesion; 2 ileus, 1 fever, 1 wound disruption) vs 3 (1 ileus, 1 fever, 1 voiding difficulty).
11 Koo et al., 2012 CR Mature cystic teratoma excision B 1 NA None.
12 Cho et al., 2012 RCT Adnexal surgery (SPL vs LPS) B 40 (20 v 20) 42 v 36 2 (1 ileus, 1 delayed ovarian bleeding) v none.
13 Fagotti et al., 2012 CS TLH + BSO + Pelvic and paraortic lymph node dissection M 100 129 8 (1 transection of obturator nerve with laparotomic conversion, 1 small tear on the inferior vena cava with 1 additional trocar insertion, 1 superficial serosal injury on small bowel, 1 paravaginal bleeding, 1 wound cellulites, 2 partial vaginal cuff dehiscence, 1 ileus).
14 Wenger et al., 2012 CS SCH with endocervical resection B 2 134 None.
15 Lee et al., 2012 CS TLH, SOB, myomectomy B e M 500 97 37 (3 bladder injury, 2 omental bleeding, 1 rectal serosa injury, 1 trocar site haematoma, 2 re-operation, 14 fever, 3 ileus, 5 vault bleeding/dehiscence, 3 wound infection, 3 other).
16 Roh et al., 2012 RC Adnexal surgery (SPL vs LPS) B 139
(96 v 43)
70 v 75 11 (8 blood transfusions, 1 wound infection, 2 ileus) v none.
17 Lazard et al., 2011 CS Cornual resection for interstitial pregnancy B 2 NA None.
18 Yoon et al., 2011 CR TLH, BSO, omentectomy, pelvic lymphadenectomy, appendectomy Borderline 1 280 None.
19 Gouy et al., 2011 CS Extraperitoneal para-aortic lymphadenectomy M 14 190 None.
20 Im et al., 2011 RC Adnexal surgery (SPL vs LPS) B 33 (18 v 15) 63 v 51 None.
21 Song et al., 2011 CS LAVH B e M 100 115 9 (5 insertion of additional ports, 1 conversion to laparotomy, 1 bleeding, 1 vesicovaginal fistula, 1 cuff abscess).
22 Yoon et al., 2011 RC Ectopic pregnancy (SPL vs LPS) B 60 (30 v 30) 53 v 47 1 (1 transfusion) vs 3 (3 transfusions).
23 Calcagno et al., 2012 CS Salpingectomy for ectopic pregnancy B 12 37 None.
24 Gunderson et al., 2012 CS TLH, SCH, SO, Myomectomy, OC B e M 211 108 10 (4 laparotomic conversion, 6 insertion of additional port).
25 Lee et al., 2011 RC LAVH (SPL vs LPS) B e M 242 (80 v 162) 93 v 90 3 (1 bladder injury, 1 transfusion, 1 fever) v 7 (2 subcutaneous emphysema, 2 bladder injury, 2 transfusions, 1 fever).
26 Kim et al., 2011 CS Adnexal surgery B e M 96 50 12 (6 cyst rupture, 2 fever, 2 insertion of additional ports, 2 conversion to laparotomy).
27 Chen et al., 2011 RCT LAVH (SPL vs LPS) B 100 (50 v 50) 122 v 127 3 (1 vaginal cuff hematoma, 2 an additional trocar) vs 2 (1 post operative anemia with a blood transfusion, 1 wound infection).
28 Chua et al., 2011 CR 10 cm ovarian cyst B 1 73 None.
29 Angioni et al., 2011 CR LAVH B 1 90 None.
30 Bedaiwy et al., 2011 CS Salpingectomy B 11 35 None.
31 Jung et al., 2011 RCT TLH (SPL vs LPS) B 68
(34 v 34)
89 v 80 17(7 fever, 1 ileus, 1 other, 1 transfusion, 1 bladder injury, 4 conversion to 2 or 4 port) vs 4 (2 fever, 1 ileus, 1 other).
32 Kavallaris et al., 2011 RC Adnexal surgery (SPL vs LPS) B 48 (24 v 24) 35 v 28 None vs None.
33 Jung et al., 2011 CS Adnexal surgery B 86 64 6 (2 conversion to 2 or 3 port; 3 postoperative infections, 1 postoperative bleeding).
34 Ramesh et al., 2011 CR Myomectomy B 1 130 None.
35 Mereu et al., 2011 CR Myomectomy B 1 94 None.
36 Phongnarisorn and Chinthakanan, 2011 CS TLH B 10 163 2 (fever).
37 Kim and Know, 2010 CR OC during pregnancy B 1 25 None.
38 Fagotti et al., 2010 CR Adnexal surgery B 30 40 None.
39 Park et al., 2011 CS TLH; SCH; adnexal surgery, myomectomy; Adhesiolysis B and M 200 113 4 bleeding and 1 vescicovaginal fistula after hysterectomy, 1 hematoma after myomectomy, 1 conversion to open, 9 insertion additional port.
40 Boruta et al., 2011 CS Pelvic and para-aortic lymphadenectomy M 5 243 None.
41 Hahn and Kim, 2010 CS Pelvic lymph node dissection + RVH M 2 178 None.
42 Kumakiri et al., 2010 CS Salpingotomy + intracorporeal suturing B 3 56 None.
43 Hart et al., 2010 CR TLH and cholecystectomy B 1 180 None.
44 Perrone et al., 2010 CR TLH + BSO B 1 90 None.
45 Escobar et al., 2010 CS Pelvic and para-aortic lymphadenectomy M 21 120 2 (1 insertion of additional trocars + 1 small vein injury).
46 Surico et al., 2010 CR OC and Cholecystectomy B 1 132 None.
47 Lee et al., 2010 CS Myomectomy, cystectomy, appendectomy B 15 81 None.
48 Fader et al., 2010 CS Adnexal surgery
LH, BSO, RLH pelvic/Para aortic lymphadenectomy
B and M 74 82 6 (3 minor; 1 conversion to conventional LPS; 2 conversion to open).
49 Kim et al, 2010 CS Myomectomy using transumbilical morcellator B 15 97 None.
50 Song et al., 2010 CS LAVH (uterus > 500 g) B 15 125 2 insertion of additional trocar.
51 Yim et al., 2010 RC TLH (SPL vs LPS) B and M 157 (52 v 105) 118 v 110 2 (1 urinary tract infection, 1 wound infection) vs 10 (2 urinary tract infection, 1 hematuria, 1 Upper respiratory infection, 1 wound infection, 2 ileus, 2 Vault bleeding, 1 Vault rupture).
52 Lee et al., 2010 RC Adnexal surgery (SPL vs LPS) B 51 (17 v 34) 64 v 58 None.
53 Kim et al., 2010 RC LAVH (SPL vs LPS) B 86 (43 v 43) 119 v 124 None.
54 Angioni et al., 2010 CS Endometrioma excision B 3 40 None.
55 Mereu et al., 2010 CS Adnexal surgery B 16 42 1 wound infection.
56 Jung et al., 2010 CS TLH B 30 100 1 insertion of additional trocar.
57 Yoon et al., 2010 CS SCH with transcervical morcellation B 7 157 None.
58 Langebrekk and Qvigstad, 2009 CR TLH B 1 60 None.
59 Fanfani et al., 2009 CR TLH M 1 120 None.
60 Gilabert-Estelles, 2010 CR TLH B 1 125 None.
61 Lee et al., 2009 CS LAVH B 24 119 6 (3 transfusion, 2 insertion of additional trocar).
62 Lim et al., 2009 CS Adnexal surgery B 12 73 None.
63 Ghezzi et al., 2005 CS Salpingectomy for tubal pregnancy B 10 27 None.
64 Kosumi et al., 2001 CR Ovarian cystectomy B 1 NA None.
65 Pelosi, 1991 CS SCH B 4 NA None.

BSO, bilateral salpingo-oophorectomy; CS, case series; CR, case report; LAVH, laparoscopic assisted vaginal hysterectomy; LPS, standard or conventional laparoscopy; M-LPS, minilaparoscopy; OC, ovarian cystectomy; PSP, promontosacropexy; RC, retrospective comparative study; RCT, randomised-controlled trial; RVH, radical vaginal hysterectomy; SCH, supracervical hysterectomy; SPL, single port laparoscopy; TLH, total laparoscopic hysterectomy.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 8, 2017 | Posted by in OBSTETRICS | Comments Off on Single port entry – Are there any advantages?

Full access? Get Clinical Tree

Get Clinical Tree app for offline access